États-Unis · Presse financière · Investor's Business Daily

Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher

Publié par Investor's Business Daily · États-Unis il y a 1 h

Rapport Therapeutics stock shot higher Tuesday on promising, but mixed, test results for its bipolar treatment. The post Can This Small Biotech Enter A $4.3 Billion AbbVie Market?…

Lire l'article complet sur Investor's Business Daily Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.investors.com)

Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher

À lire aussi

11 of the Best Financial Advisor Companies: Well-Known Fiduciary Investment Firms to Consider

Seagate and Western Digital Stocks Sank Last Week. Why Morgan Stanley Would Be ‘Aggressive Buyers.’

Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher

Partager

À lire aussi

11 of the Best Financial Advisor Companies: Well-Known Fiduciary Investment Firms to Consider

Seagate and Western Digital Stocks Sank Last Week. Why Morgan Stanley Would Be ‘Aggressive Buyers.’